Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9671 |
High Similarity |
NPD4965 |
Approved |
0.9671 |
High Similarity |
NPD4966 |
Approved |
0.9671 |
High Similarity |
NPD4967 |
Phase 2 |
0.9474 |
High Similarity |
NPD37 |
Approved |
0.9419 |
High Similarity |
NPD6234 |
Discontinued |
0.913 |
High Similarity |
NPD7228 |
Approved |
0.8938 |
High Similarity |
NPD7199 |
Phase 2 |
0.8909 |
High Similarity |
NPD7240 |
Approved |
0.8712 |
High Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.8287 |
Intermediate Similarity |
NPD7680 |
Approved |
0.8208 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.8167 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.8113 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8075 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.807 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8059 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8057 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7798 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.775 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7727 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7719 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7714 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7684 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7679 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7661 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7657 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7633 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7614 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7613 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.759 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7574 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7572 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7564 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7527 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7515 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7515 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7515 |
Intermediate Similarity |
NPD2533 |
Approved |
0.75 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7486 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7486 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7472 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7471 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7468 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7468 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7446 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7444 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7442 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.743 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.743 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7421 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7384 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7374 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7368 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7368 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7353 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7329 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7303 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7301 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7301 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7301 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7301 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7301 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7301 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7301 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD7827 |
Phase 1 |
0.7294 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.729 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7258 |
Intermediate Similarity |
NPD7296 |
Approved |
0.7256 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD4140 |
Approved |
0.725 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.725 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7249 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7241 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7235 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7233 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7216 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7209 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7178 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7169 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7143 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7134 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7134 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7126 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD919 |
Approved |
0.7097 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7093 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7073 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7066 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7062 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7062 |
Intermediate Similarity |
NPD6746 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7045 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7043 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7041 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7041 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7039 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7039 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.703 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7019 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7018 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7013 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7006 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD5401 |
Approved |
0.6995 |
Remote Similarity |
NPD6780 |
Approved |
0.6995 |
Remote Similarity |
NPD6778 |
Approved |
0.6995 |
Remote Similarity |
NPD6779 |
Approved |
0.6995 |
Remote Similarity |
NPD6782 |
Approved |
0.6995 |
Remote Similarity |
NPD6776 |
Approved |
0.6995 |
Remote Similarity |
NPD6781 |
Approved |
0.6995 |
Remote Similarity |
NPD6777 |
Approved |
0.6994 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6994 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6994 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD5735 |
Approved |
0.6994 |
Remote Similarity |
NPD1933 |
Approved |
0.6988 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6987 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6983 |
Remote Similarity |
NPD5711 |
Approved |
0.6983 |
Remote Similarity |
NPD5710 |
Approved |
0.6981 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6968 |
Remote Similarity |
NPD5126 |
Approved |
0.6964 |
Remote Similarity |
NPD7003 |
Approved |
0.6964 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6959 |
Remote Similarity |
NPD1512 |
Approved |
0.6957 |
Remote Similarity |
NPD7095 |
Approved |
0.6954 |
Remote Similarity |
NPD5283 |
Phase 1 |
0.6943 |
Remote Similarity |
NPD2981 |
Phase 2 |
0.6937 |
Remote Similarity |
NPD5736 |
Approved |
0.6937 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6932 |
Remote Similarity |
NPD5353 |
Approved |
0.6928 |
Remote Similarity |
NPD4476 |
Approved |
0.6928 |
Remote Similarity |
NPD2531 |
Phase 2 |
0.6928 |
Remote Similarity |
NPD4477 |
Approved |
0.6928 |
Remote Similarity |
NPD2796 |
Approved |
0.6927 |
Remote Similarity |
NPD2973 |
Approved |
0.6927 |
Remote Similarity |
NPD1247 |
Approved |
0.6927 |
Remote Similarity |
NPD2975 |
Approved |
0.6927 |
Remote Similarity |
NPD2974 |
Approved |
0.6923 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6914 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD3268 |
Approved |
0.6907 |
Remote Similarity |
NPD4580 |
Approved |
0.6906 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6905 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6903 |
Remote Similarity |
NPD1651 |
Approved |
0.6903 |
Remote Similarity |
NPD5691 |
Approved |
0.69 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.69 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD447 |
Suspended |
0.6888 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6888
|
Remote Similarity |
NPD7697 |
Approved |